Fact checked by Nick Blackmer Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the ...

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...

233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

Purpose: The pharmacology, pharmacokinetics, efficacy, safety, drug interactions, dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic ...

The recall of the Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, was initiated on October 10 and has been given the second highest risk classification by the FDA.

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

The recall involves 7,101 bottles of duloxetine delayed-release capsules distributed nationwide within the United States, according to the FDA. The recalled capsules are 20mg in strength, and sold in ...

The agency is specifically recalling 7,107 bottles of duloxetine delayed-release capsules manufactured by Towa Pharmaceutical Europe. The capsules are 20 milligram doses and come in bottles of 500 ...